The United Kingdom has approved the mRNA vaccine developed by Moderna, securing an additional 10 million doses to its initial 7 million: but supplies aren’t expected until spring. Despite procuring 17 million doses of the vaccine, a rollout isn’t anticipated for some time, with Moderna vaguely stating that “deliveries of the COVID-19 Vaccine … from […] Continue reading ->
Ibadan, Nigeria. Several Nigerian states were unable to carry out preventative yellow fever campaigns late last year because of the COVID-19 pandemic, leaving thousands of people at risk of developing the disease as the country now faces a new winter yellow fever outbreak, Health Policy Watch learned. In early November, Nigeria’s Center for Disease Control […] Continue reading ->
The redacted WHO report on Italy’s pandemic response, “An Unprecedented Challenge” contained a brief timeline of events in the early days of the SARS-CoV-2 outbreak in China, which a number of WHO officials sought to amend or suppress even before the entire report was recalled. In fact, the so-called “China box” on the outbreak’s early […] Continue reading ->
The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns.   Mass vaccinations were […] Continue reading ->
The WHO-led COVAX Facility announced Friday that it has now secured some 2 billion vaccine doses and distribution of vaccines will begin in the first quarter of 2021 – ensuring that at least some vaccines will begin to reach the 92 low-income countries that are largely dependent on global philanthropy to access sufficient vaccine supplies. […] Continue reading ->
Moderna’s COVID-19 vaccine was set to be approved by the US Food and Drug Administration (FDA), following a near-unanimous endorsement by an expert panel that reviewed its clinical trial results. Meanwhile, at US$ 18 per dose, the Moderna vaccine will also be the most expensive vaccine to go on the market soon, according to a […] Continue reading ->